Results 91 to 100 of about 172,191 (165)

Modulation of Chemotherapy Sensitivity of Breast Cancer Cells through Transforming Growth Factor-beta Pathway-mediated Alterations in DNA Damage Response. [PDF]

Int J Med Sci
Alhamed AS, El-Wetidy MS, Abdelwahed MM, Attia SM, Alabkka AM, Alaraj SA, Alhazzani K, Alanazi AZ, Almutairi F, Alotibi IA, Alqinyah M.   +10 more
europepmc   +1 more source

Salivary Interleukin-13 and Transforming Growth Factor Beta as Potential Biomarkers of Cancer Cachexia. [PDF]

Cancers (Basel)
Belev B, Vičić I, Sedlić F, Prtorić M, Soče M, Prejac J, Potočki S, Silovski T, Herceg D, Kulić A.   +9 more
europepmc   +1 more source

Fibulin-4 and latent-transforming growth factor beta-binding protein-4 interactions with syndecan-2 and syndecan-3 are required for elastogenesis. [PDF]

FASEB J
Hakami H, Dinesh NEH, Nelea V, Lamarche-Vane N, Ricard-Blum S, Reinhardt DP.   +5 more
europepmc   +1 more source

α-Asarone attenuates tumor-associated macrophages-induced gemcitabine resistance in pancreatic carcinoma via the transforming growth factor-beta 1/growth factor independent 1 axis. [PDF]

Anticancer Drugs
Yu J, Xue Y, Gao Z, Hu L, Liu X, He X, Wang X.   +6 more
europepmc   +1 more source

Comparative evaluation of transforming growth factor-beta 1 release from dentin matrix with double antibiotic paste, probiotics, and simvastatin as intracanal medicaments: An <i>in vitro</i> study. [PDF]

J Conserv Dent Endod
Reddy KH, Prasanthi G, Devipriya B, Malini DL, Mohan TM, Agarwal V.   +5 more
europepmc   +1 more source

Transforming growth factor beta-1 (TGF-β1) expression in patients with adenomyosis. [PDF]

Rev Bras Ginecol Obstet
Jacobo A, Borges RF, de Souza CAB, Genro VK, Cunha-Filho JS.   +4 more
europepmc   +1 more source

miR-335-3p attenuates transforming growth factor beta 1-induced fibrosis by suppressing Thrombospondin 1. [PDF]

PLoS One
Han DH, Shin MK, Sung JS, Kim M.
europepmc   +1 more source

Milk levels of transforming growth factor beta 1 identify mothers with low milk supply. [PDF]

PLoS One
Sullivan R, Confair A, Hicks SD.
europepmc   +1 more source

MiR-301b-3p promotes breast cancer development through inhibiting the expression of transforming growth factor-beta receptor 2. [PDF]

PeerJ
Lou J, Liu X, Xie Y, Wu M, Mao W, Ying X.   +5 more
europepmc   +1 more source